WuXi PharmaTech Appoints Edward Hu as Chief Financial Officer
Aug 11, 2010
Aug 11, 2010 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced the appointment of Edward Hu as Chief Financial Officer effective immediately. Mr. Hu has served as the company's Chief Operating Officer since January 2008 and previously served as acting CFO from February 2009 through May 2010. Hao Zhou, the current CFO, is leaving WuXi to pursue other opportunities and will assist in the transition.
"I am confident that Ed's familiarity with our business and our industry and his previous tenure as acting CFO will enable him to lead our finance team to even better performance," commented Dr. Ge Li, Chairman and CEO. "We thank Hao for his contribution to building a strong finance team under Ed's leadership, and we wish him well in his future endeavors."
About WuXi AppTec and WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, we provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners to improve the success of research and shorten the time of development cost effectively in discovering and developing drugs and medical devices. Please visit: http://www.wuxiapptec.com.